These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17110327)

  • 1. CFTR: new members join the fold.
    Skach WR
    Cell; 2006 Nov; 127(4):673-5. PubMed ID: 17110327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.
    Wang X; Venable J; LaPointe P; Hutt DM; Koulov AV; Coppinger J; Gurkan C; Kellner W; Matteson J; Plutner H; Riordan JR; Kelly JW; Yates JR; Balch WE
    Cell; 2006 Nov; 127(4):803-15. PubMed ID: 17110338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70.
    Farinha CM; Nogueira P; Mendes F; Penque D; Amaral MD
    Biochem J; 2002 Sep; 366(Pt 3):797-806. PubMed ID: 12069690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator.
    Namkung W; Kim KH; Lee MG
    Gastroenterology; 2005 Dec; 129(6):1979-90. PubMed ID: 16344066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.
    Du K; Sharma M; Lukacs GL
    Nat Struct Mol Biol; 2005 Jan; 12(1):17-25. PubMed ID: 15619635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correctors promote folding of the CFTR in the endoplasmic reticulum.
    Loo TW; Bartlett MC; Clarke DM
    Biochem J; 2008 Jul; 413(1):29-36. PubMed ID: 18361776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folding of CFTR is predominantly cotranslational.
    Kleizen B; van Vlijmen T; de Jonge HR; Braakman I
    Mol Cell; 2005 Oct; 20(2):277-87. PubMed ID: 16246729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topogenesis of cystic fibrosis transmembrane conductance regulator (CFTR): regulation by the amino terminal transmembrane sequences.
    Chen M; Zhang JT
    Biochemistry; 1999 Apr; 38(17):5471-7. PubMed ID: 10220334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones.
    Wang Y; Bartlett MC; Loo TW; Clarke DM
    Mol Pharmacol; 2006 Jul; 70(1):297-302. PubMed ID: 16624886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CFTR-Associated Ligand Arrests the Trafficking of the Mutant ΔF508 CFTR Channel in the ER Contributing to Cystic Fibrosis.
    Bergbower E; Boinot C; Sabirzhanova I; Guggino W; Cebotaru L
    Cell Physiol Biochem; 2018; 45(2):639-655. PubMed ID: 29402832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Inhibitors of the Hsp90-Aha1 Protein Complex, a Potential Target to Drug Cystic Fibrosis, by Alpha Technology.
    Ihrig V; Obermann WMJ
    SLAS Discov; 2017 Aug; 22(7):923-928. PubMed ID: 28346090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misfolded proteins in the endoplasmic reticulum.
    Perlmutter DH
    Lab Invest; 1999 Jun; 79(6):623-38. PubMed ID: 10378505
    [No Abstract]   [Full Text] [Related]  

  • 13. Is it go or NO go for S-nitrosylation modification-based therapies of cystic fibrosis transmembrane regulator trafficking?
    Zeitlin PL
    Mol Pharmacol; 2006 Oct; 70(4):1155-8. PubMed ID: 16877677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of calpain in the regulation of CFTR (cystic fibrosis transmembrane conductance regulator) turnover.
    Averna M; Stifanese R; Grosso R; Pedrazzi M; De Tullio R; Salamino F; Pontremoli S; Melloni E
    Biochem J; 2010 Sep; 430(2):255-63. PubMed ID: 20557290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing of CFTR: traversing the cellular maze--how much CFTR needs to go through to avoid cystic fibrosis?
    Amaral MD
    Pediatr Pulmonol; 2005 Jun; 39(6):479-91. PubMed ID: 15765539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic reticulum-associated degradation of mutant CFTR requires a guanine nucleotide-sensitive step.
    De Keukeleire B; Micoud J; Biard J; Benharouga M
    Int J Biochem Cell Biol; 2008; 40(9):1729-42. PubMed ID: 18280771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misfolding of the cystic fibrosis transmembrane conductance regulator and disease.
    Cheung JC; Deber CM
    Biochemistry; 2008 Feb; 47(6):1465-73. PubMed ID: 18193900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes.
    Sharma M; Pampinella F; Nemes C; Benharouga M; So J; Du K; Bache KG; Papsin B; Zerangue N; Stenmark H; Lukacs GL
    J Cell Biol; 2004 Mar; 164(6):923-33. PubMed ID: 15007060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator.
    Xiong X; Bragin A; Widdicombe JH; Cohn J; Skach WR
    J Clin Invest; 1997 Sep; 100(5):1079-88. PubMed ID: 9276724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of F508del-CFTR trafficking by the sponge alkaloid latonduine is modulated by interaction with PARP.
    Carlile GW; Keyzers RA; Teske KA; Robert R; Williams DE; Linington RG; Gray CA; Centko RM; Yan L; Anjos SM; Sampson HM; Zhang D; Liao J; Hanrahan JW; Andersen RJ; Thomas DY
    Chem Biol; 2012 Oct; 19(10):1288-99. PubMed ID: 23102222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.